Cancer Therapies

Cancer therapies encompass several primary approaches: chemotherapy uses drugs to kill rapidly dividing cancer cells, radiation therapy targets tumors with high-energy beams, immunotherapy harnesses the immune system to fight cancer, and targeted therapy attacks specific cancer cell mutations. Each approach may be used alone or combined depending on cancer type and stage.

Chemotherapy uses cytotoxic drugs designed to kill or damage cancer cells by interfering with cell division and DNA replication. These drugs circulate throughout the body, targeting rapidly dividing cells characteristic of cancer. While effective, chemotherapy can also affect healthy cells, leading to side effects. Treatment typically occurs in cycles to allow normal cell recovery between doses.

Immunotherapy strengthens the body's natural immune response to recognize and destroy cancer cells. It works by removing barriers that prevent immune cells from attacking tumors or by enhancing immune cell activity. This approach leverages the immune system's ability to distinguish cancer cells from healthy tissue, offering a different mechanism than traditional chemotherapy or radiation.

Targeted therapy focuses on specific genetic mutations or proteins present in cancer cells rather than broadly attacking all dividing cells. By identifying and exploiting unique cancer cell characteristics, targeted therapy can be more precise and potentially cause fewer side effects than chemotherapy. This personalized approach requires genetic testing to match patients with appropriate targeted drugs.

Radiation therapy uses high-energy beams to damage cancer cell DNA, preventing replication and causing cell death. It can be delivered externally or internally and is often used to shrink tumors, relieve symptoms, or eliminate remaining cancer after surgery. Radiation may be combined with chemotherapy or other therapies to improve treatment outcomes.

Clinical trials test new cancer treatment approaches in human patients to evaluate safety, efficacy, and optimal dosing. They provide evidence for regulatory approval and help identify which therapies work best for specific cancer types and patient populations. Participation advances medical knowledge and may offer patients access to innovative treatments before widespread availability.